Moosheer Alammar
Overview
Explore the profile of Moosheer Alammar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao Y, Wendt S, Krohn S, Alammar M, Junghanss C, Nolte I, et al.
Anticancer Res
. 2024 Aug;
44(9):3843-3848.
PMID: 39197916
Background/aim: Uveal melanoma (UM) represents a prevailing primary intraocular malignancy, with a limited median overall survival among metastatic patients, and most tumors lack RAF/RAS mutations. The pan-RAF inhibitor LY3009120 has...
2.
Gao Y, Packeiser E, Wendt S, Sekora A, Cavalleri J, Pratscher B, et al.
Genes (Basel)
. 2024 Feb;
15(2).
PMID: 38397192
Malignant melanomas (MMs) are the abnormal proliferation of melanocytes and are one of the lethal skin cancers in humans, equines, and canines. Accordingly, MMs in companion animals can serve as...
3.
Ladwig A, Gupta S, Ehlers P, Sekora A, Alammar M, Koczan D, et al.
Molecules
. 2023 Dec;
28(24).
PMID: 38138609
Thiazolopyridines are a highly relevant class of small molecules, which have previously shown a wide range of biological activities. Besides their anti-tubercular, anti-microbial and anti-viral activities, they also show anti-cancerogenic...
4.
Najjar F, Alammar M, Al-Massarani G, Almalla N, Japawe A, Ikhtiar A
Lung Cancer
. 2018 Oct;
124:23-30.
PMID: 30268466
Objectives: It has been proposed that circulating endothelial cells (CECs) and microparticles (MPs) may be useful for the assessment of patients with non-small-cell lung cancer (NSCLC). However, little is known...
5.
Alarfi H, Salamoon M, Kadri M, Alammar M, Haykal M, Alseoudi A, et al.
BMC Res Notes
. 2017 Nov;
10(1):550.
PMID: 29096707
Objective: The prognostic value of body mass index (BMI) in metastatic breast cancer (MBC) has not been fully elucidated. In a prospective study to investigate the chemo-sensitizing effect of statins...
6.
Najjar F, Al-Massarani G, Banat I, Alammar M
Int J Biol Markers
. 2015 Jun;
30(4):e374-81.
PMID: 26109363
Background: Circulating endothelial cells (CECs) reflect the neovascularization in the tumor mass. We therefore investigated the potential role of CEC kinetics after first-line chemotherapy in advanced non-small cell lung cancer...
7.
Najjar F, Alammar M, Bachour M, Al-Massarani G
Int J Biol Markers
. 2014 Jul;
29(4):e337-44.
PMID: 25041783
Background: Circulating endothelial cells (CECs) have been proposed as a biomarker for the assessment of patients with solid tumors. However, few data are available in non-small cell lung cancer (NSCLC)....
8.
Najjar F, Alammar M, Bachour M, Almalla N, Altahan M, Alali A, et al.
J Cancer Res Clin Oncol
. 2014 Jul;
141(1):119-25.
PMID: 25037116
Purpose: Monitoring circulating endothelial cells (CECs) count reflects the tumor vasculature in cancer patients and might be a predictor of response to chemotherapy. We therefore investigated the clinical significance of...